Sirine Abou Al Hassan1,2, Darren Cutinha2, Lama Mattar3. 1. Dietetic Department, Saint George Hospital University Medical Center, Beirut, Lebanon. 2. Division of Medicine, Eating Disorders and Clinical Nutrition, University College London, London, UK. 3. Nutrition Division, Department of Natural Sciences, School of Arts and Sciences, Lebanese American University, Beirut, Lebanon. Lama.mattar@lau.edu.lb.
Abstract
PURPOSE: The genetic aspect of anorexia nervosa (AN) involving specific genes of the central-nervous-system has not yet been clearly understood. The aim of this systematic review is to assess the impact of three candidate genes of the brain: catechol-O-methyltransferase, brain-derived neurotrophic factor (BDNF) and serotonin transporter protein, on the susceptibility to AN and identify whether a clear connection persists between each of the gene-polymorphisms and AN. METHODS: A total of 21 articles were selected for this review conforming to the PRISMA guidelines. Detailed keyword combinations were implemented within specific databases such as MEDLINE, SCIENCEDIRECT and PUBMED. RESULTS: The catechol-O-methyltransferase gene-polymorphism did not show any change in phenotypic variation between AN and control subjects; but the familial association was rather strong with an over-transmission of the H allele. The latter also correlated with several dimensions of the Temperament and Character Inventory (TCI) scale. A notable relation was indicated between BDNF gene-polymorphism and anorexia-restrictive in terms of phenotypic distribution; the Met66-allele also depicted high association with anorexic behavioral traits. The 5-HTTLPR gene-polymorphism was found to be significantly associated with AN susceptibility with an over-transmission of the S-allele from parents to offspring. CONCLUSION: The systematic review distinctively emphasized the genetic contribution of the brain-genes on the development of AN. Despite significant study findings, no clear and standardized genetic route was determined to be the cause of AN development. Future research is needed on these specific genes to closely monitor the genetic polymorphisms and their mechanism on AN susceptibility. LEVEL OF EVIDENCE: I, systematic review.
PURPOSE: The genetic aspect of anorexia nervosa (AN) involving specific genes of the central-nervous-system has not yet been clearly understood. The aim of this systematic review is to assess the impact of three candidate genes of the brain: catechol-O-methyltransferase, brain-derived neurotrophic factor (BDNF) and serotonin transporter protein, on the susceptibility to AN and identify whether a clear connection persists between each of the gene-polymorphisms and AN. METHODS: A total of 21 articles were selected for this review conforming to the PRISMA guidelines. Detailed keyword combinations were implemented within specific databases such as MEDLINE, SCIENCEDIRECT and PUBMED. RESULTS: The catechol-O-methyltransferase gene-polymorphism did not show any change in phenotypic variation between AN and control subjects; but the familial association was rather strong with an over-transmission of the H allele. The latter also correlated with several dimensions of the Temperament and Character Inventory (TCI) scale. A notable relation was indicated between BDNF gene-polymorphism and anorexia-restrictive in terms of phenotypic distribution; the Met66-allele also depicted high association with anorexic behavioral traits. The 5-HTTLPR gene-polymorphism was found to be significantly associated with AN susceptibility with an over-transmission of the S-allele from parents to offspring. CONCLUSION: The systematic review distinctively emphasized the genetic contribution of the brain-genes on the development of AN. Despite significant study findings, no clear and standardized genetic route was determined to be the cause of AN development. Future research is needed on these specific genes to closely monitor the genetic polymorphisms and their mechanism on AN susceptibility. LEVEL OF EVIDENCE: I, systematic review.
Entities:
Keywords:
Anorexia nervosa; BDNF and 5-HTT; Brain genes; COMT
Authors: Bernie Devlin; Silviu-Alin Bacanu; Kelly L Klump; Cynthia M Bulik; Manfred M Fichter; Katherine A Halmi; Allan S Kaplan; Michael Strober; Janet Treasure; D Blake Woodside; Wade H Berrettini; Walter H Kaye Journal: Hum Mol Genet Date: 2002-03-15 Impact factor: 6.150
Authors: M Ribasés; M Gratacòs; L Armengol; R de Cid; A Badía; L Jiménez; R Solano; J Vallejo; F Fernández; X Estivill Journal: Mol Psychiatry Date: 2003-08 Impact factor: 15.992
Authors: Andrew M McIntosh; Ben J Baig; Jeremy Hall; Dominic Job; Heather C Whalley; G Katherine S Lymer; T William J Moorhead; David G C Owens; Patrick Miller; David Porteous; Stephen M Lawrie; Eve C Johnstone Journal: Biol Psychiatry Date: 2006-10-02 Impact factor: 13.382